Solazyme, Inc. Files Registration Statement for Proposed Initial Public Offering

March 11, 2011

For Immediate Release

SOUTH SAN FRANCISCO, California (March 11, 2011) — Solazyme, Inc., a renewable oil company and leader in industrial biotechnology, announced today the company has filed a registration statement on Form S-1 with the Securities and Exchange Commission (SEC) for a proposed initial public offering. Morgan Stanley & Co. Incorporated and Goldman, Sachs & Co. will act as joint book-running managers for the offering with Pacific Crest Securities and Lazard Capital Markets as co-managers. The number of shares to be sold in the proposed offering and the offering price have not yet been determined.

A copy of the prospectus relating to these securities may be obtained, when available, from: Morgan Stanley & Co. Incorporated, Prospectus Department, 1585 Broadway, New York, NY 10036 or Goldman, Sachs & Co., Prospectus Department, 200 West Street, New York, NY 10282.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any State in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such State.

About Solazyme

Solazyme, Inc. is a renewable oil company and a leader in industrial biotechnology. Founded in 2003 and headquartered in South San Francisco, Solazyme’s proprietary technology transforms a range of low-cost plant-based sugars into high-value oils. Our renewable products can replace or enhance oils derived from the world’s three existing sources—petroleum, plant and animal fats. We tailor the composition of our oils to address specific customer requirements, offering superior performance characteristics at a competitive cost to conventional oils. Solazyme's oils and fuels provide compelling solutions to increasingly complex issues of fuel scarcity, energy security and environmental impact while fitting into the pre-existing multi-trillion dollar fuel infrastructure. Solazyme's investors, among others, include Braemar Energy Ventures, Harris & Harris Group, Lightspeed Venture Partners, The Roda Group, VantagePoint Venture Partners, and Zygote Ventures. For more information, please visit www.solazyme.com.

For more information

Genet Garamendi
VP, Corporate Communications
(650) 963-5228
press@solazyme.com

About Braemar Energy Ventures

Braemar Energy Ventures is a venture capital fund making early- to mid-stage investments in the energy technology sector. The firm's principals have invested in more than 60 companies in the sector and have more than 100 years of combined technical, operational and financial experience in energy and energy-related industries. Braemar partners with exceptional companies and management teams, in both alternative and traditional energy markets, that can contribute to a more profitable and efficient energy landscape through innovation and marketplace expertise. Additional information is available at BraemarEnergy.com or on Twitter at twitter.com/braemarenergy or @BraemarEnergy.

For more information

Alison McIntyre
Prosek Partners
(212) 279-3115 x269
amcintyre@prosek.com